International differences in evolution of early discharge after acute myocardial infarction.
D000208:Acute Disease; D001315:Australia; D003431:Cross-Cultural Comparison; D005060:Europe; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D005500:Follow-Up Studies; D017048:Health Care Costs; D006760:Hospitalization / Q000191:economics / Q000706:statistics & numerical data; D006801:Humans; D007902:Length of Stay / Q000191:economics / Q000706:statistics & numerical data*; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D009313:National Health Programs / Q000191:economics; D009520:New Zealand; D004369:Pentetic Acid; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D015996:Survival Rate; D016896:Treatment Outcome; D014481:United States
D005343:Fibrinolytic Agents; D004369:Pentetic Acid